top of page
検索
LIFE.14 inc
2018年4月1日読了時間: 1分

ACCJ The Journal - Advance Medicine - AstraZeneca Japan President Stefan Woxström shares his healthc


APRIL 2018 HEALTH

Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision

By C Bryan Jones

Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year.

The ACCJ - 在日米国商工会議所

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

APRIL 2018 HEALTH Advance Medicine AstraZeneca Japan President Stefan Woxström shares his healthcare vision By C Bryan Jones Biopharmaceutical company AstraZeneca says science is at the heart of everything they do. With an unprecedented six new treatments expected to come to market in 2018, the company has life-changing breakthroughs in store for patients in Japan. Guiding efforts here is Stefan Woxström, who relocated in January from Sweden, where he headed up the company’s operations in the Nordic and Baltic countries. The ACCJ Journal sat down with Woxström to find out more about AstraZeneca’s approach to healthcare and why 2018 is a milestone year. https://journal.accj.or.jp/advance-medicine/ The ACCJ - 在日米国商工会議所 http://www.accj.or.jp

閲覧数：85回
最新記事
特集記事
bottom of page